October 2026

Standard Operating Procedures (SOPs), cGMP requirements, and safety standards, ensuring consistent production of high-quality pharmaceutical products while meeting productivity, compliance, and quality objectives.

A team from Flinders University’s Biomedical Nanoengineering Laboratory has found that vanillin has pronounced antioxidant, anti-inflammatory and antibacterial properties, making it a good candidate for wound-healing formulations.

AstraZeneca has completed its 2 billion USD equity investment in Summit Therapeutics, strengthening a strategic partnership focused on advancing ivonescimab, a potential first-in-class bispecific antibody targeting PD-1 and VEGF, in combination with antibody-drug conjugates (ADCs) across multiple cancer types.

Zydus Lifesciences Limited, in partnership with MSN Laboratories Private Limited, has launched Riociguat Tablets in the United States, becoming the first companies to market a generic version of Bayer’s Adempas® (riociguat) in the country.

The Drugs Consultative Committee (DCC) has proposed a prominent statutory warning on cough syrup labels restricting their use in children below four years of age, amid concerns over the widespread prescribing of cough syrups to young children.

A major prospective clinical trial has identified clinical and molecular characteristics that may help determine which patients with early-stage HER2-positive breast cancer are most likely to achieve a pathologic complete response (pCR) after a shorter, less intensive chemotherapy regimen.

A cancer drug currently being evaluated in clinical trials may work through a different biological mechanism than scientists originally believed, according to a new study led by the University of Sydney in collaboration with Goethe University, the University of Oxford and the Institute of Cancer Research, London.

India’s national telemedicine service eSanjeevani has crossed the landmark of 50 crore teleconsultations, highlighting the growing role of digital healthcare in improving access to medical services across the country.

MSc / PharmD / MPharm / MTech (Life Sciences / Molecular Biology / Biotechnology / Pharmacy Practice preferred. Manipal Academy of Higher Education